Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Diastereomeric Salt Formation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel resolution method using L-Tyrosine methyl ester achieves >99.5% ee. Cost-effective, scalable process for pharmaceutical intermediates.
Patent CN100546969C details a cost-effective resolution method for 2-hydroxymethyl-3-phenylpropionic acid using N-Octylglucamine, offering high optical purity for pharmaceutical synthesis.
Patent CN102603592B reveals a novel DBTA resolution method for chiral aminopyrrolidines, offering high yield and optical purity for pharmaceutical supply chains.
Patent CN109734653B details a superior chiral resolution method for Argatroban precursors using L-dibenzoyltartaric acid, offering enhanced purity and cost-effective manufacturing scalability.
Patent CN101743218B reveals a superior resolution method for trans-2-aminocyclohexanol using 2-methoxyphenylacetic acid, offering high yield and cost-effective manufacturing for pharmaceutical intermediates.